France· FR:66990599
NOVOEIGHT 250 UI, poudre et solvant pour solution injectable
A turoctocog alfa product containing turoctocog alfa, registered in France by NOVO NORDISK (DANEMARK). The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Turoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD43 (turoctocog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Turoctocog alfa · ATC B02BD43
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TUROCTOCOG ALFA
- Manufacturer
- NOVO NORDISK (DANEMARK)
- Country
- France (FR)
- ATC code
- B02BD43
- ATC class
- Turoctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009585739581 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 4 ml avec adaptateur(s) pour flacon
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Turoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNovoEight 250 IE poeder en oplosmiddel voor oplossing voor injectieNovo Nordisk A.S.
- SwedenNovoEight 1000 IE Pulver och vätska till injektionsvätska, lösningNovo Nordisk A/S
- CanadaZONOVATENOVO NORDISK CANADA INC
- CzechiaNOVOEIGHTNovo Nordisk A/S, Bagsvaerd
- SpainNOVOEIGHT 1000 UI UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- FinlandNovoeightNovo Nordisk A/S
- BelgiumNovoEight 1000 IUNovo Nordisk
- United KingdomNovoEight 1,000unit powder and solvent for solution for injection vialsNovo Nordisk Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Novoeight
- Norway · Novoeight
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df08d31a-80b7-4bb2-93a5-baa64ff9f1a4 GET /v1/drugs/df08d31a-80b7-4bb2-93a5-baa64ff9f1a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66990599",
"date_amm": "2013-11-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/888",
"substance": "TUROCTOCOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about turoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.